Stephens & Co. Maintains Overweight on Vericel, Raises Price Target to $68
Benzinga Newsdesk 13 hours ago
Analyst RatingsNewsPrice Target
Stephens & Co. analyst Mason Carrico maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from $55 to $68.
Stephens & Co. analyst Mason Carrico maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from $55 to $68.